DNA affects the composition of lipoplex protein corona: A proteomics approach

Proteomics

Volumn 11, Issue 16, 2011, Pages 3349-3358

  Capriotti, Anna L ^a   Caracciolo, Giulio ^a   Caruso, Giuseppe ^a   Foglia, Patrizia ^a   Pozzi, Daniela ^a   Samperi, Roberto ^a   Laganà, Aldo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Biomedicine; Differences analysis; LC MS MS; Liposomes; Nanomedicine; Plasma

Indexed keywords

3 [N (N ,N DIMETHYLAMINOETHANE)CARBAMOYL] CHOLESTEROL; COMPLEMENT; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA; FIBRONECTIN; HISTONE; LIPID; LIPOPLEX; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE SYSTEM; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEOMICS;

ADSORPTION; ADULT; BLOOD PROTEINS; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; GENE TRANSFER TECHNIQUES; HUMANS; LIPOSOMES; MASS SPECTROMETRY; NANOCONJUGATES; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; PROTEIN BINDING; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 79960748365     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000803     Document Type: Article

References (40)

1. Dalgleish, A. G., Why: gene therapy? Gene Ther. 1997, 4, 629-630.
2. Factor, P., Gene therapy for acute diseases. Mol. Ther. 2001, 4, 515-524.
3. Nishikawa, M., Huang, L., Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 2001, 12, 861-870.
4. Lu, D. R., Zhou, J. M., Zheng, B., Qiu, X. F. et al., Stage I clinical trial of gene therapy for hemophilia B. Sci. China B Chem. Life Sci. Earth Sci. 1993, 36, 1342-1351.
5. Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J. et al., Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 2000, 24, 257-261.
6. Fields, P. A., Arruda, V. R., Armstrong, E., Chu, K. et al., Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9. Mol. Ther. 2001, 4, 201-210.
7. Drittanti, L., Jenny, C., Poulard, K., Samba, A. et al., Optimised helper virus-free production of high-quality adeno-associated virus vectors. J. Gene Med. 2001, 3, 59-71.
8. Nakai, H., Storm, T. A., Kay, M. A., Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol. 2000, 18, 527-532.
9. Duan, D., Yue, Y., Yan, Z., Engelhardt, J. F., A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat. Med. 2000, 6, 595-598.
10. Sun, L., Li, J., Xiao, X., Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. 2000, 6, 599-602.
11. Tros de Ilarduya, C., Arangoa, M. A., Moreno-Aliaga, M. J., Düzgüne°, N., Enhanced gene delivery in vitro and in vivo by tansferrin-lipoplexes. Biochim. Biophys. Acta 2002, 1561, 209-221.
12. De la Torre, L. G., Rosada, R. S., Fávaro Trombone, A. P., Frantz, F. G. et al., The synergy between structural stability and DNA binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes. Colloids Surf. B Biointerfaces 2009, 73, 175-184.
13. Rädler, J. O., Koltover, I., Salditt, T., Safinya, C. R., Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 1997, 275, 810-814.
14. Walczyk, D., Baldelli Bombelli, F., Monopoli, M. P., Lynch, I., Dawson, K. A., What the Cell "Sees" in Bionanoscience. J. Am. Chem. Soc. 2010, 132, 5761-5768.
15. Lynch, I., Salvati, A., Dawson, K. A., Protein-nanoparticle interactions: What does the cell see? Nat. Nanotech. 2009, 4, 546-547.
16. Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G. et al., Physicalchemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133, 2525-2534.
17. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 383-392.
18. Keller, A., Eng, J., Zhang, N., Li, X. J. et al., A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol. Syst. Biol. 2005, 1, 1-8.
19. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
20. Capriotti, A. L., Caracciolo, G., Caruso, G., Cavaliere, C. et al., Analysis of plasma protein adsorption onto DC-Chol-DOPE cationic liposomes by HPLC-CHIP coupled to a Q-TOF mass spectrometer. Anal. Bioanal. Chem. 2010, 398, 2895-2903.
21. Cedervall, T., Lynch, I., Foy, M., Berggård, T. et al., Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. Engl. 2007, 119, 5856-5858.
22. Cedervall, T., Lynch, I., Lindman, S., Berggard, T. et al., Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. USA 2007, 104, 2050-2055.
23. Jefferis, R., Kumararatne, D. S., Selective Igg subclass deficiency: Quantification and clinical relevance. Clin. Exp. Immunol. 1990, 81, 357-367.
24. Labarre, D., Vauthier, C., Chauvierre, C., Petri, B. et al., Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 2005, 26, 5075-5084.
25. Anderson, N. L., Anderson, N. G., The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
26. Sitrin, R. G., Pan, P. M., Srikanth, S., Todd, R. F., Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J. Immunol. 1998, 161, 1462-1470.
27. Rubel, C., Fernandez, G. C., Dran, G., Bompadre, M. B. et al., Fibrinogen promotes neutrophil activation and delays apoptosis. J. Immunol. 2001, 166, 2002-2010.
28. McNally, A. K., Anderson, J. M., Complement C3 participation in monocyte adhesion to different surfaces. Proc. Natl. Acad. Sci. USA 1994, 91, 10119-10123.
29. Luck, M., Schroder, W., Paulke, B. R., Blunk, T. et al., Complement activation by model drug carriers for intravenous application: determination by two-dimensional electrophoresis. Biomaterials 1999, 20, 2063-2068.
30. Salvador-Morales, C., Flahaut, E., Sim, E., Sloan, J., Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 2006, 43, 193-201.
31. Caracciolo, G., Foglia, P., Fuscoletti, V., Giancanti, P. et al., Existence of hybrid structures in cationic liposome/DNA complexes revealed by their interaction with plasma proteins. Colloid Surf. B 2011, 82, 141-146.
32. Caracciolo, G., Callipo, L., Candeloro De Sanctis, S., Cavaliere, C. et al., Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum. Biochim. Biophys. Acta 2010, 1798, 536-543.
33. Iwanami, K., Matsumoto, I., Yoshiga, Y., Inoue, A. et al., Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide. Arthritis Res.Ther. 2009, 11, 1-14.
34. Schubert, D., Schmidt, M., Zaiss, D., Jungblut, P. R., Kamradt, T., Autoantibodies against GPI and creatine kinase in rheumatoid arthritis. Nat. Immunol. 2002, 3, 411.
35. Doolittle, R. F., The multiplicity of domains in proteins. Ann. Rev. Biochem. 1995, 64, 287-314.
36. Gardner, W. D., Haselby, J. A., Hoch, S. O., Identification of a major serum DNA-binding protein as factor B of the alternative complement pathway. J. Immunol. 1980, 124, 2800-2806.
37. Tan, Y., Liu, F., Li, Z., Li, S., Huang, L., Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol. Ther. 2001, 3, 673-682.
38. Zhang, J., Liu, F., Conwell, C. C., Tan, Y. et al., Mechanistic Studies of Sequential Injection of Cationic Liposome and Plasmid DNA. Mol. Ther. 2006, 13, 429-437.
39. Deng, Z. J., Mortimer, G., Schiller, T., Musumeci, A. et al., Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009, 20, 455101, 9pp.
40. Lundqvist, M., Stigler, J., Elia, G., Lynch, I. et al., Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 2008, 105, 14265-14270.